Literature DB >> 1661624

Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor.

L Bover1, M Barrio, I Slavutsky, A I Bravo, C Quintans, A Bagnăti, B Lema, J Schiaffi, R Yomha, J Mordoh.   

Abstract

The establishment of a new human breast cancer cell line (IIB-BR-G) was successful after a previous growth of the cells isolated from a breast primary tumor in a female nude mouse. The IIB-BR-G cell line and the primary tumor do not express estrogen or progesterone receptors. Vimentin and keratin expression were found in the cell line and in the nude mouse tumor. This cell line displays high morphological heterogeneity with atypical multinucleated megacells, and it is capable of anchorage-independent growth and tumor formation in nude mice. The cytogenetic analysis confirmed its human origin and revealed multiple marker chromosomes and extensive chromosomal alterations including rearrangements, gains, losses, isochromosomes, and double minutes (DMs).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661624     DOI: 10.1007/bf01975204

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  44 in total

1.  Isolation of two human tumor epithelial cell lines from solid breast carcinomas.

Authors:  E Y Lasfargues; W G Coutinho; E S Redfield
Journal:  J Natl Cancer Inst       Date:  1978-10       Impact factor: 13.506

2.  Different intermediate-sized filaments distinguished by immunofluorescence microscopy.

Authors:  W W Franke; E Schmid; M Osborn; K Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

3.  Tissue culture studies on pleural effusions from breast carcinoma patients.

Authors:  R Cailleau; B Mackay; R K Young; W J Reeves
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

4.  Breast tumor cell lines from pleural effusions.

Authors:  R Cailleau; R Young; M Olivé; W J Reeves
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

5.  Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line.

Authors:  P Masiakowski; R Breathnach; J Bloch; F Gannon; A Krust; P Chambon
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

6.  Cytogenetic analysis in human breast carcinoma. II. Seven cases in the triploid/tetraploid range investigated using direct preparations.

Authors:  S M Hill; C S Rodgers; M A Hultén
Journal:  Cancer Genet Cytogenet       Date:  1987-01

7.  Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle.

Authors:  R L Sutherland; M D Green; R E Hall; R R Reddel; I W Taylor
Journal:  Eur J Cancer Clin Oncol       Date:  1983-05

8.  Establishment and characterization of three new continuous cell lines derived from human breast carcinomas.

Authors:  L W Engel; N A Young; T S Tralka; M E Lippman; S J O'Brien; M J Joyce
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

Review 9.  The biology of breast cancer at the cellular level.

Authors:  H S Smith; S R Wolman; A J Hackett
Journal:  Biochim Biophys Acta       Date:  1984

10.  Expression of keratin and vimentin intermediate filaments in rabbit bladder epithelial cells at different stages of benzo[a]pyrene-induced neoplastic progression.

Authors:  I C Summerhayes; Y S Cheng; T T Sun; L B Chen
Journal:  J Cell Biol       Date:  1981-07       Impact factor: 10.539

View more
  6 in total

1.  Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells.

Authors:  C Ballaré; M Barrio; P Portela; J Mordoh
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

2.  Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells.

Authors:  María Marcela Barrio; Riad Abes; Marina Colombo; Gabriela Pizzurro; Charlotte Boix; María Paula Roberti; Emmanuelle Gélizé; Mariana Rodriguez-Zubieta; José Mordoh; Jean-Luc Teillaud
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

3.  Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice.

Authors:  María Paula Roberti; Juan Martín Arriaga; Michele Bianchini; Héctor Ramiro Quintá; Alicia Inés Bravo; Estrella Mariel Levy; José Mordoh; María Marcela Barrio
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

4.  Cetuximab and IL-15 Promote NK and Dendritic Cell Activation In Vitro in Triple Negative Breast Cancer.

Authors:  Estefanía Paula Juliá; José Mordoh; Estrella Mariel Levy
Journal:  Cells       Date:  2020-06-28       Impact factor: 6.600

5.  A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression.

Authors:  Erika M von Euw; María M Barrio; David Furman; Estrella M Levy; Michele Bianchini; Isabelle Peguillet; Olivier Lantz; Alejandra Vellice; Abraham Kohan; Matías Chacón; Cassian Yee; Rosa Wainstok; José Mordoh
Journal:  J Transl Med       Date:  2008-01-25       Impact factor: 5.531

6.  Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells.

Authors:  Estefanía Paula Juliá; Analía Amante; María Betina Pampena; José Mordoh; Estrella Mariel Levy
Journal:  Front Immunol       Date:  2018-09-20       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.